None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adults over 40 2) Patients who are taking amyloid PET / CT due to neurologic dementia specialist suspected of cognitive decline worse than MCI.
Exclusion criteria
Exclusion criteria: 1) When it is difficult to cooperate with interview and self-question (literacy, hearing impairment, speech disorder) 2) Patients who cannot consent through the patient or guardian 3) Patients with a medical condition that cannot undergo PET test History of neurological / psychiatric disorders (territorial cerebral infarction, severe head trauma, brain surgery, intracranial hematoma with permanent brain lesion, major affective disorder, schizophrenia, or schizo-affective disorder) 5) If patients are undergoing radiation therapy or are undergoing radiation exposure in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of target protein difference between positive and negative patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Analyzing whether the amount of target protein reflects severity of dementia | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital